Observational study links PADI4 haplotypes to wound healing and infection risk in diabetes

This abstract reports an observational study investigating the association between PADI4 haplotypes and wound healing outcomes in 687 surgical patients, of whom 44.7% had diabetes mellitus (DM). The study compared minor versus major PADI4 haplotypes as the exposure, with primary outcomes of delayed wound healing and infections.

Key findings include that PADI4 expression in DM patients was 9.4-fold higher, and PADI4 mRNA and protein expression in neutrophils were increased in those with the minor haplotype. NET production occurred in larger quantities more rapidly, and the highest rates of delayed wound healing and infections were observed in patients with DM carrying the minor haplotype. However, specific effect sizes, p-values, or confidence intervals for these outcomes were not reported.

The authors note a limitation: circulating NET markers likely reflect established tissue damage and offer limited opportunity for early intervention. The study does not provide details on setting, follow-up duration, or funding.

While the authors suggest that PADI4 haplotyping may provide a clinically actionable biomarker to identify patients with DM at high risk for wound healing complications, the observational design and lack of reported statistical precision warrant restrained interpretation. Further confirmatory studies are needed before clinical application.